Ana gezinime atla
Aramaya atla
Ana içeriğe atla
Sıralama ölçütü
Medicine and Dentistry
ST Segment Elevation Myocardial Infarction
100%
Primary Percutaneous Coronary Intervention
91%
Myocardial Infarction
64%
Anterior Myocardial Infarction
53%
Carotid Artery Stenting
51%
Hospital Mortality
41%
Pulmonary Embolism
41%
CHA2DS2-VASc Score
38%
Coronary Artery
32%
Long-Term Outcome
28%
Fibrinolytic Therapy
26%
Blood Clot Lysis
26%
Cardiogenic Shock
24%
Electrocardiography
23%
Nutrition Assessment
23%
Apoplexy
23%
Thrombus
22%
Transthoracic Echocardiography
19%
Mortality Rate
19%
ST Elevation
19%
Thorax Pain
16%
Regression Analysis
16%
In-Stent Restenosis
15%
Two Dimensional Speckle Tracking Echocardiography
15%
Systemic Immune Inflammation Index
15%
Contrast-Induced Nephropathy
15%
Atrial Fibrillation
15%
Acute Coronary Syndrome
14%
Proportional Hazards Model
13%
R Wave
13%
Q Wave
13%
Stent Thrombosis
13%
Multivariate Analysis
12%
Percutaneous Coronary Intervention
12%
Lymphocyte
12%
Coronary Artery Bypass Graft
11%
Artery Thrombosis
11%
Pseudoaneurysm
11%
Diastolic Function
11%
Hazard Ratio
10%
Congestive Heart Failure
10%
Restenosis
10%
Infarction
10%
Electrocardiogram
10%
Hypertension
10%
Glucose
10%
Acute Pulmonary Embolism
10%
Obstruction
10%
Right Coronary Artery
10%
Three Dimensional Echocardiography
10%
Keyphrases
ST-elevation Myocardial Infarction (STEMI)
93%
Primary Percutaneous Coronary Intervention (pPCI)
71%
Pulmonary Embolism
42%
Atrial Fibrillation
38%
In-hospital Mortality
35%
Thrombolytic Therapy
35%
CHA2DS2-VASc Score
30%
Prognostic Value
28%
Predictive Value
27%
Acute Pulmonary Embolism
25%
Long-term Mortality
25%
Carotid Artery Stenting
23%
No-reflow
23%
Clinical Outcomes
17%
Cardiogenic Shock
16%
95% Confidence Interval
15%
Acute Anterior Myocardial Infarction
15%
Prognostic nutritional Index
15%
TIMI Risk Index
15%
Turkish Adults
15%
Neutrophil-to-lymphocyte Ratio
15%
Plasma Osmolality
15%
Contrast-induced Acute Kidney Injury (CI-AKI)
15%
Risk of Death
15%
Electrocardiographic Parameters
15%
Thrombolysis in Myocardial Infarction Score
15%
Patient Outcomes
15%
Paroxysmal Atrial Fibrillation
13%
Blood Urea Nitrogen
13%
Anticoagulation
11%
Tissue Plasminogen Activator (t-PA)
11%
Anterior Myocardial Infarction
10%
Odds Ratio
10%
ST-segment Elevation
10%
Right Coronary Artery
10%
Nitrogen Levels
10%
Thrombus
9%
Percutaneous Coronary Intervention
9%
Comorbidity
9%
Anterior ST-segment Elevation Myocardial Infarction
8%
Middle-aged
8%
Left Anterior Descending Artery
8%
Acute Myocardial Infarction
8%
Inflammation
8%
Long-term Clinical Outcome
8%
Major Bleeding
8%
Myocardial Infarction
8%
Electrocardiogram
8%
Prognostic Significance
7%
Coronary Artery Bypass Grafting
7%
Pharmacology, Toxicology and Pharmaceutical Science
ST Segment Elevation Myocardial Infarction
58%
Hospital Mortality
57%
Lung Embolism
46%
Heart Infarction
38%
Fibrinolytic Agent
35%
Thrombus
23%
Mortality Rate
22%
Atrial Fibrillation
19%
Cardiogenic Shock
16%
All Cause Mortality
15%
Pneumonia
15%
Dipeptidyl Carboxypeptidase Inhibitor
14%
Cerebrovascular Accident
14%
High Density Lipoprotein Cholesterol
11%
Acute Coronary Syndrome
10%
Heart Ventricle Arrhythmia
10%
Acute Heart Infarction
9%
Ischemic Heart Disease
9%
Bleeding
9%
Hypertension
9%
Biological Marker
9%
Congestive Heart Failure
8%
Takotsubo Cardiomyopathy
7%
Antiarrhythmic Drug
7%
Potassium
7%
Liver Fibrosis
7%
In-Stent Restenosis
7%
Apixaban
7%
Hyperosmolality
7%
Fibrosis
7%
Angiotensinogen
7%
Receptor Blocking Agent
7%
Obstruction
7%
Coronavirinae
7%
Brain Natriuretic Peptide
7%
Creatine Kinase Isoenzyme
7%
Rhabdomyolysis
7%
Artery Thrombosis
7%
Contrast Induced Nephropathy
7%
Isotopes of Potassium
7%
Hypokalemia
7%
Antivitamin K
7%
Antithrombotic Therapy
7%
Cholesterol
7%
Inflammation
7%
Tirofiban
7%
Acute Heart Failure
7%
Nonalcoholic Fatty Liver
7%
Hypertensive Crisis
7%
Overall Survival
6%
